-
Chordoma_Exome_Sequencing
Study
EGAS00001000188
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928
-
Chordoma_Targeted_Sequencing_Study
Study
EGAS00001000280
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
Integrated Genomic, Epigenetic, and Expression Analyses of Ovarian Cancer Cell Lines
Study
EGAS00001002998
-
Whole genome sequencing of acral melanomas
Study
EGAS00001000486
-
Feasibility Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab (OpACIN) in resectable stage III melanoma patients
Study
EGAS00001003099
-
POT1_splice_site_mutant_analysis
Study
EGAS00001000571
-
Pre-neoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma
Study
EGAS00001005656